4.7 Article

New secondary metabolites with immunosuppressive and BChE inhibitory activities from an endophytic fungus Daldinia sp. TJ403-LS1

Journal

BIOORGANIC CHEMISTRY
Volume 114, Issue -, Pages -

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bioorg.2021.105091

Keywords

Daldinia sp; TJ403-LS1; Anoectochilus roxburghii; Structural elucidation; BChE inhibitory activity; Immunosuppressive activity

Funding

  1. National Natural Science Foundation [81725021]
  2. Innovative Research Groups of the National Natural Science Foundation of China [81721005]
  3. National Natural Science Foundation of China [21702067, 81573316]
  4. Tongji-Rongcheng Center for Biomedicine, Huazhong University of Science and Technology [0231514141]
  5. Research and Development Program of Hubei Province [2020BCA058]
  6. Hubei Provincial Natural Science Foundation of China [2019CFB646]

Ask authors/readers for more resources

Several new compounds were isolated from the endophytic fungus Daldinia sp. TJ403-LS1, with compound 1 showing remarkable immunosuppressive and BChE inhibitory activities, indicating their potential for pharmaceutical development.
Five new acetylenic phenol derivatives (1-4 and 7), one new benzofuran derivative (8), one new naphthol derivative (9), and two known analogues (5 and 6), were isolated and identified from an endophytic fungus Daldinia sp. TJ403-LS1 that was isolated from the medicinally valuable plant Anoectochilus roxburghii. Their structures were elucidated by means of extensive spectroscopic analyses and electronic circular dichroism (ECD) calculations. In addition, compound 1 exhibited remarkable immunosuppressive activity against LPS and antiCD3/anti-CD28 mAbs activated murine splenocytes proliferation with the same IC50 values of 0.06 mu M and BChE inhibitory activity with an IC50 value of 6.93 +/- 0.71 mu M, and compounds 6, 8 and 9 showed excellent BChE inhibitory activity with IC50 values of 16.00 +/- 0.30, 23.33 +/- 0.55, and 15.53 +/- 0.39 mu M, respectively (positive drug neostigmine, IC50 = 49.60 +/- 6.10 mu M), highlighting the promising potentials to be designed and developed as immunosuppressive and BChE inhibitory agents.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available